| scholarly article | Q13442814 |
| P50 | author | Alessandro Doria | Q54241891 |
| Wiwit Tantibhedhyangkul | Q80140149 | ||
| P2093 | author name string | Watip Boonyasrisawat | |
| Nattachet Plengvidhya | |||
| Suwattanee Kooptiwut | |||
| Asako Doi | |||
| Hiroto Furuta | |||
| Kishio Nanjo | |||
| Napatawn Banchuin | |||
| Pa-thai Yenchitsomanus | |||
| Napat Songtawee | |||
| Masahiro Nishi | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2821-2826 | |
| P577 | publication date | 2007-04-10 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | PAX4 mutations in Thais with maturity onset diabetes of the young | |
| P478 | volume | 92 |
| Q37592282 | A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell |
| Q33734037 | Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes |
| Q51323776 | Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients. |
| Q39735026 | Challenges for molecular diagnosis of familial early-onset diabetes in unexplored populations |
| Q35997281 | Clinical features and treatment of maturity onset diabetes of the young (MODY). |
| Q37095214 | Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes |
| Q35140726 | Deconstructing pancreas development to reconstruct human islets from pluripotent stem cells |
| Q39029575 | Epigenetic control of β-cell function and failure |
| Q48477844 | Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals. |
| Q34066401 | Gene-specific function prediction for non-synonymous mutations in monogenic diabetes genes |
| Q89294643 | Generation and Phenotype Identification of PAX4 Gene Knockout Rabbit by CRISPR/Cas9 System |
| Q37214389 | Genetic Determinants of Type 2 Diabetes in Asians |
| Q54973025 | Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives. |
| Q37639793 | Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. |
| Q36828628 | Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. |
| Q50880858 | Glucokinase mutations in pediatric patients with impaired fasting glucose. |
| Q57241781 | Historical Overview of Gene Discovery Methodologies in Type 2 Diabetes |
| Q36479367 | Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a |
| Q55177646 | Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population. |
| Q37242220 | Investigating maturity onset diabetes of the young. |
| Q33622236 | Many faces of monogenic diabetes |
| Q26771916 | Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know? |
| Q92499637 | Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment |
| Q37015978 | Molecular diagnosis of maturity onset diabetes of the young in India |
| Q57915399 | Monogenic Causes of Diabetes |
| Q36960085 | Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes |
| Q90540588 | Monogenic Forms of Diabetes Mellitus |
| Q43805190 | Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia |
| Q26995562 | New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism |
| Q41301920 | Overexpression of PAX4 reduces glucagon expression in differentiating hESCs |
| Q38231866 | PAX genes in childhood oncogenesis: developmental biology gone awry? |
| Q40391278 | PAX4 Defines an Expandable β-Cell Subpopulation in the Adult Pancreatic Islet |
| Q36756843 | PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment |
| Q38762768 | PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects. |
| Q48318871 | Regenerating β cells of the pancreas - potential developments in diabetes treatment. |
| Q34206308 | Revealing transcription factors during human pancreatic β cell development |
| Q36084435 | Searching for "monogenic diabetes" in dogs using a candidate gene approach |
| Q38731193 | Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors. |
| Q38116916 | The endocrine pancreas: insights into development, differentiation, and diabetes |
| Q37962349 | The role of pancreatic imaging in monogenic diabetes mellitus |
| Q38162099 | Transcriptional control of mammalian pancreas organogenesis |
| Q27009451 | Translational implications of the β-cell epigenome in diabetes mellitus |
| Q28083025 | Undiagnosed MODY: Time for Action |
| Q96303797 | Update on clinical screening of maturity-onset diabetes of the young (MODY) |
| Q40223049 | Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention |
| Q83156785 | [Maturity onset diabetes of the young (MODY)] |
Search more.